Anti-Human MAP Kinase-Activating Death Domain (CT) (MADD)

Anti-Human MAP Kinase-Activating Death Domain (CT) (MADD)

Product No.: M1021

[product_table name="All Top" skus="M1021"]

- -
- -
Target
MADD
Product Type
Polyclonal Antibody
Alternate Names
DENN
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:M1207
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human MAP Kinase-Activating Death Domain (MADD) recognizes Human, Mouse and Rat MADD. This polyclonal antibody was purified using affinity chromatography.
Background
MAP kinase-activating death domain protein (MADD) was initially identified as the type 1 tumor necrosis factor receptor (TNFR1) associated protein though their death domains. Overexpression of MADD activates MAP kinases ERK and JNK and induces the phosphorylation of cytosolic phospholipase A2. MADD shares 98% identity with DENN (for differentially expressed in neoplastic vs. normal cells), which was recently identified as a substrate for c-jun N-terminal kinase 3 (JNK3). MADD has greater than 94% overall identity to a GDP/GTP exchange protein Rab3-GEP. MADD is 87% identical to KIAA0358, a brain protein of unknown function. Identification of MADD as a component of the TNFR1 signaling complex and the similarity between MADD and Rab3-GEP provides a connection between TNFR1 activation and downstream MAP kinase activity through a guanine-nucleotide exchange protein.

Antigen Details

PubMed

References & Citations

1. Schievella, AR. et al. (1997) J. Biol. Chem. 272:12069
2. Chow, VT. et al. (1996) DNA Seq. 6:263
3. Zhang, Y. et al. (1998) Proc. Natl. Acad. Sci. USA 95:2586
4. Brown, TL. et al. (1998) Curr. Biol. 8:R191
IHC FFPE
General Western Blot Protocol

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.